Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

What's really behind the male infertility crisis? New study seeks answers

This comprehensive study in Nature Reviews Urology tackles critical questions in male infertility, from its diagnosis and treatment to its impact on overall health. The review calls for a deeper understanding of male reproductive issues, better diagnostic methods, and improved public and medical awareness of the topic.

15 Oct 2023

Immune system proteins play role in early stages of Huntington's disease

Huntington's Disease is the most common neurodegenerative disorder controlled by a single gene and is characterized by motor and cognitive deficits and psychiatric symptoms.

12 Oct 2023

BioLizard launches new BioVerse Platform to accelerate life sciences R&D processes

BioLizard, the bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry, today announced the launch of its new BioVerse platform.

12 Oct 2023

New glutamine sensor could revolutionize early diagnosis and treatment of geriatric diseases

In 2023, life expectancy in Korea will be 83.6 years, the third highest among OECD countries, and it is steadily increasing every year.

11 Oct 2023

Digital Twin Brain: A bridge between biological and artificial intelligence

Recent developments in neuroscience and brain-inspired artificial intelligence have opened up new possibilities in understanding intelligence.

11 Oct 2023

Wearable devices and machine learning revolutionize Parkinson's disease monitoring

The quantitative progression of motor symptoms of Parkinson's disease (PD) over time using wearable sensor data.

11 Oct 2023

Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1.

From Owlstone Medical Ltd 10 Oct 2023

Saliva test breakthrough: Early detection for ectopic pregnancies on the horizon

Salivary proteins may offer early detection for ectopic pregnancies, potentially saving maternal lives through a non-invasive diagnostic approach. The study identifies specific proteins that are prominently present in ruptured ectopic pregnancy cases, highlighting the potential for developing a saliva-based diagnostic kit.

9 Oct 2023

International report paves way for precision diabetes medicine breakthrough

Precision medicine for prevention, diagnosis, treatment, and prognosis for Diabetes.

9 Oct 2023

Non-invasive eye exam could be a valuable tool for early detection of cerebral small vessel disease

A research team led by the Keck School of Medicine of USC has discovered that a non-invasive eye exam may be a possible tool for screening Black Americans and other people from underdiagnosed and high-risk populations for cerebral small vessel disease, a major contributor to cognitive impairment and dementia.

6 Oct 2023

Researchers identify two main pathways involved in Alzheimer's disease

Dementia, which includes Alzheimer's disease, currently affects around 1.8 million people in Germany. The exact cause has not yet been clarified, but genetic factors play a significant role in the development of the disease.

6 Oct 2023

Blood test for pan-cancer biomarker could revolutionize early cancer detection

Diagnostic tools for timely, accurate and inexpensive early cancer detection that can assess risk or monitor response to treatment could help patients get the care they need faster and improve existing care strategies.

5 Oct 2023

Researchers discover a vulnerability in immunotherapy-resistant triple-negative breast cancer

Researchers at Vanderbilt-Ingram Cancer Center have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.

5 Oct 2023

Measuring ctDNA may lead to alternative treatment options for BRAF wild-type melanoma

Circulating tumor DNA (ctDNA) is emerging as a blood-based biomarker for many solid tumor types, including melanoma.

4 Oct 2023

New insights into how smoking influences certain metabolites to increase type 2 diabetes risk

New research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct) finds that cigarette smoking increases the risk of developing type 2 diabetes in part by affecting a variety of metabolites - small chemicals produced in the processes of metabolism - that circulate in the bloodstream.

3 Oct 2023

Genomic testing rates soar for Black patients with prostate cancer after introduction of precision medicine navigators

The presence of a clinical navigator to act as a liaison between people with prostate cancer and the health care system greatly increases the likelihood that patients, especially Black patients, will receive advanced testing that can help predict the severity of their disease and guide treatment, a new study suggests.

3 Oct 2023

Biomarker News and Research

Further Reading

What's really behind the male infertility crisis? New study seeks answers

Immune system proteins play role in early stages of Huntington's disease

BioLizard launches new BioVerse Platform to accelerate life sciences R&D processes

New glutamine sensor could revolutionize early diagnosis and treatment of geriatric diseases

Digital Twin Brain: A bridge between biological and artificial intelligence

Wearable devices and machine learning revolutionize Parkinson's disease monitoring

Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy

Saliva test breakthrough: Early detection for ectopic pregnancies on the horizon

International report paves way for precision diabetes medicine breakthrough

Non-invasive eye exam could be a valuable tool for early detection of cerebral small vessel disease

Researchers identify two main pathways involved in Alzheimer's disease

Blood test for pan-cancer biomarker could revolutionize early cancer detection

Researchers discover a vulnerability in immunotherapy-resistant triple-negative breast cancer

Measuring ctDNA may lead to alternative treatment options for BRAF wild-type melanoma

New insights into how smoking influences certain metabolites to increase type 2 diabetes risk

Genomic testing rates soar for Black patients with prostate cancer after introduction of precision medicine navigators

Novel deep learning model to assess Alzheimer's disease progression risk

Identification of Alzheimer's disease-associated micro-RNA biomarkers through network-based analysis

New research reveals how social isolation impacts behavior and lifespan in social species

Extending FDA-approved cancer drug indications requires high patient numbers, study finds

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo